Ovation.io and PDTx announce the completion of their merger. The new entity creates an industry-leading multiomics data company managed by a team with deep expertise in genomics data, sequencing, bioinformatics, cell biology, and imaging, AI/ML and data commercialization. The Company’s enhanced platform capabilities and data libraries can drive deeper insights into cellular biology and gene expression for research, drug development, and clinical decision-making, and across a broad range of diseases.
Read the full article: Ovation.io and PD Theranostics (PDTx) Complete Merger //
Source: https://www.prnewswire.com/news-releases/ovationio-and-pd-theranostics-pdtx-complete-merger-creating-a-multiomic-data-company-which-owns-a-unique-population-scale-biobank-of-disease-specific-biospecimens-302239632.html